President
Patient Advocates In Research (PAIR)
Danville, California
Deborah Collyar has been a leader in patient engagement and advocacy since her first cancer diagnosis iin 1990. Her business leadership, IT, and communication skills bridge gaps between scientists, medical providers, and patients. Deborah founded the Patient Advocates in Research (PAIR) international communication network in 1996, "where research meets reality," and consults with health and medical research communities.
Deborah has infused hundreds of patient advocates into health research while delivering innovative ways to gather input from thousands of patients from diverse communities. Her work encompasses many diseases, programs and policies at grassroots, national and international levels with companies, academia, governments, and Patient Advocacy Groups. Key insights are delivered throughout a variety of topics, including development processes, clinical trials and product life cycles, genomic testing, results reporting, data-sharing and DCT, standards and best practices, health literacy, DEI, disclosure/transparency, risk/benefit analysis, and healthcare delivery and assessment.
Deborah has been a key member in pivotal projects with the CRUK, NIH, NCI Clinical Trials Network (NCTN), ASCO, AACR, Antibacterial Resistance Leadership Group (ARLG), Clinical Trials Transformation Initiative (CTTI), Center for Medical Technology Policy (CMTP), DIA, Institute of Clinical and Economic Review (ICER), Metastatic Breast Cancer Alliance (MBCA), Multi-Regional Clinical Trials Center (MRCT), Oncology Research Information Exchange Network (ORIEN), and others. She is an author, grant team member, presenter, and faculty at workshops like the Vail Methods in Clinical Research and the SITC Winter School. She and her husband have survived 3+ cancers, and they work with multiple communities and patients.
Disclosure(s): Advisory Board: M2GEN (Ongoing), PAREXEL International Inc. (Ongoing); Consultant: Apellis, Inc. (Ongoing), IQVIA Ltd. (Ongoing), Kinnate Biopharma (Ongoing), MaxisIT (Ongoing); Speaker's Bureau: Merck (Terminated), Pfizer, Inc. (Terminated)
Friday, October 14, 2022
4:40 PM – 5:25 PM
Friday, October 14, 2022
4:40 PM – 4:55 PM
Friday, October 14, 2022
5:10 PM – 5:25 PM